> top > docs > PMC:7461420 > spans > 15064-15332 > annotations

PMC:7461420 / 15064-15332 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T85 69-76 Body_part denotes glycine http://purl.org/sig/ont/fma/fma82753

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T89 182-186 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T155 14-22 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T156 96-103 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T157 104-106 http://purl.obolibrary.org/obo/CLO_0008337 denotes P4
T158 117-119 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T159 145-152 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T160 163-166 http://purl.obolibrary.org/obo/CLO_0001310 denotes 351
T161 180-181 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T96 4-13 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T97 69-76 Chemical denotes glycine http://purl.obolibrary.org/obo/CHEBI_15428|http://purl.obolibrary.org/obo/CHEBI_29947|http://purl.obolibrary.org/obo/CHEBI_57305
T100 96-103 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670
T101 104-106 Chemical denotes P4 http://purl.obolibrary.org/obo/CHEBI_35895
T102 145-152 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
501 132-136 Gene denotes ACE2 Gene:59272
505 182-190 Species denotes SARS‐CoV Tax:694009
509 69-76 Chemical denotes glycine MESH:D005998
511 242-254 Disease denotes cytotoxicity MESH:D064420

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T156 0-268 Sentence denotes The antiviral activity was further improved when they introduced the glycine binding linkage of peptide P4 (residues 22–47) with an ACE2‐derived peptide (residues 351–357) against a SARS‐CoV‐1 pseudovirus with an IC50 of 100 nM and devoid of cytotoxicity up to 200 µM.